Emergency Medicine Cardiac Research and Education Group





CRUSADE National Quality Improvement Initiative

CRUSADE, a national quality improvement initiative, is designed to increase the practice of evidenced-based medicine for patients with diagnosed non-ST-segment-elevation acute coronary syndromes (NSTE ACS).

CRUSADE will use as its "gold standard", the NSTE ACS clinical practice guidelines developed by the American College of Cardiology (ACC) and the American Heart Association (AHA). Feedback to clinicians about care patterns and educational interventions will be used as strategies to improve the standard of care.

CRUSADE should raise physician awareness of and increase the application of the ACC/AHA guidelines for care of patients with acute coronary syndromes. Patients will benefit from this project.

For more information visit the CRUSADE website or send an email.


ADVANCING THE STANDARD of CARE: CARDIOVASCULAR, NEUROVASCULAR AND INFECTIOUS EMERGENCIES
ADVANCING THE STANDARD of CARE: CARDIOVASCULAR, NEUROVASCULAR AND INFECTIOUS EMERGENCIES
Follow-up Monograph from the ACEP 2007 Symposium
(Seattle, WA ACEP Scientific Assembly)

METHOD OF DELIVERY:
  1. Want to see it Live? View the web cast
  2. Complete Monograph (6.8 MB): download here
  3. Request a hardcopy Here!
CHAPTERS:
  1. Introduction and Table of Contents

  2. Diagnosis of TIA and Stroke in the ED: How Can This Be Made More Consistent?
    (Brian A. Stettler, MD)    

  3. Treatment of Stroke: Why the Controversy?
    (Arthur M. Pancioli, MD)    

  4. Hypertension Management in Acute Neurovascular Emergencies
    (Arthur M. Pancioli, MD)    

  5. Management of Hypertensive Emergencies in the Emergency Department
    (Judd E. Hollander, MD and Anna Marie Chang, MD)    

  6. Sick or Not Sick? Evolving Biomarkers for Severe Bacterial Infection
    (Andra L. Blomkalns, MD)    

  7. Treatment of Sepsis: How to Make Early Goal Directed Therapy a Consist ent Approach in Your ED
    (Emanuel P. Rivers, MD)    

  8. Risk Stratification for Patients with Non-ST -Segment Elevation Acute Coronary Syndromes in the ED
    (Gerard X. Brogan, MD)    

  9. Optimal Management of Non-ST-Segment Elevation ACS: The Role of Antithrombotic Therapy in the ED based on the new ACC/AHA Guidelines
    (James W. Hoekstra, MD)    

  10. Optimal AntiPlatelet Therapy for NSTE ACS: The 2007 ACC/AHA Guidelines
    (Charles V. Pollack, MD)    

  11. Best Treatment for STEMI: PCI and Fibrinolytics
    (Brian R. Holroyd, MD)    

  12. Acute Heart Failure Syndromes: Redefining Heart Failure in the ED
    (Alan B. Storrow, MD)    

  13. Pulmonary Embolism and Deep Venous Thrombosis: Evaluation and Treatment in the Emergency Department
    (Charles B. Cairns, MD)    

  14. CME Post Test






General navigation: Home | Member roster | Consultation | Our history | Contact
News & Events: Literature news archives | EM and related events
Education: Symposium monographs | CME monographs | Articles & Print | Multimedia
Publications: Member publications | Monographs

Legal information

EMCREG™ - International
Department of Emergency Medicine
University of Cincinnati College of Medicine
ML 0769, Room 6107
231 Albert Sabin Way
Cincinnati, Ohio 45267-0769

Fell free to contact us toll-free at 1-866-4EMCREG (436-2734)



Advanced Search

28 January 2010
Study results show that the TIMI risk score predicts outcomes in in emergency department with suspected ACS.
28 January 2010
Serial measurement of NT-proBNP predicts new-onset heart failure and cardiovascular mortality in elderly.
15 January 2010
Individual risk profiling of ACS patients could optimize therapeutic treatment choices.
15 January 2010
Results of the PLATO trial show that the reversible P2Y12 inhibitor ticagrelor reduces death and cardiovascular events compared with clopidogrel therapy in ACS patients.
5 January 2010
Study shows that high sensitive cardiac troponin I level is a useful prognostic marker of mortality in chronic heart failure patients.
23 December 2009
The largest and most comprehensive meta-analysis ever concludes that CRP is unlikely to be a causal factor for cardiovascular disease.
16 December 2009
Research shows that a substantial number of STEMI patients still receive fibrinolytic therapy at PCI capable centers.
11 December 2009
Denmark researchers report in Lancet that relative risk for hospitalization for bleeding increased with all drug combinations and with each additional drug used.
3 December 2009
Researchers report that prehospital triage significantly reduces treatment delay and improves outcomes in STEMI patients who undergo PCI.
30 November 2009
Researchers report that the to reperfusion, beginning with symptom onset time, determines the extent of reversible myocardial injury in STEMI patients undergoing PCI.
19 November 2009
Data presented at the AHA 2009 Scientific Sessions shows that dabigatran when added to dual anti-platelet therapy results in a “low and acceptable bleeding rate” in AMI patients.
19 November 2009
A must-read update for the management of acute coronary syndrome.
19 November 2009
Data presented at the AHA 2009 Scientific Sessions indicates that CT angiography in the emergency room can successfully triage at-risk chest-pain patients faster and cheaper than standard of care testing.
19 November 2009
Recent meta-analysis reveals that high-risk STEMI patients given adjunctive glycoprotein (GP) IIb/IIIa inhibitor therapy and undergo primary angioplasty have a reduced risk for death.
NEWS ARCHIVES:
©Copyright EMCREG-International™. All rights reserved